No Man

Sign in

Join Free
Post RFQ

Naquotinib

TypeName: Business Offer

Category:

Offer Date:2019/09/04

Country: United States

Summary: Naquotinib is an irreversible, third-generation, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity with IC50 of 8-33 nM toward EGFR mutants. https://www.bocsci.com/naquotinib-cas-1448232-80-1-item-475727.html

Description:

OfferId: 5458

Name:Alex Brown

Telphone:

Email:[email protected]